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abstractBACKGROUND: Bacteremia is now an uncommon presentation to the children’s emergency department (ED) but is
associated with signiﬁcant morbidity and mortality. Its evolving etiology may affect the ability of clinicians to
initiate timely, appropriate antimicrobial therapy.
METHODS: A retrospective time series analysis of bacteremia was conducted in the Alder Hey Children’s Hospital
ED between 2001 and 2011. Data on signiﬁcant comorbidities, time to empirical therapy, and antibiotic
susceptibility were recorded.
RESULTS: A total of 575 clinical episodes were identiﬁed, and Streptococcus pneumoniae (n = 109), Neisseria
meningitidis (n = 96), and Staphylococcus aureus (n = 89) were commonly isolated. The rate of bacteremia was
1.42 per 1000 ED attendances (95% conﬁdence interval: 1.31–1.53). There was an annual reduction of 10.6%
(6.6%–14.5%) in vaccine-preventable infections, and an annual increase of 6.7% (1.2%–12.5%) in Gram-negative
infections. The pneumococcal conjugate vaccine was associated with a 49% (32%–74%) reduction in
pneumococcal bacteremia. The rate of health care–associated bacteremia increased from 0.17 to 0.43 per 1000 ED
attendances (P = .002). Susceptibility to empirical antibiotics was reduced (96.3%–82.6%; P , .001). Health
care–associated bacteremia was associated with an increased length of stay of 3.9 days (95% conﬁdence interval:
2.3–5.8). Median time to antibiotics was 184 minutes (interquartile range: 63–331) and 57 (interquartile range:
27–97) minutes longer in Gram-negative bacteremia than in vaccine-preventable bacteremia.
CONCLUSIONS: Changes in the etiology of pediatric bacteremia have implications for prompt, appropriate empirical
treatment. Increasingly, pediatric bacteremia in the ED is health care associated, which increases length of inpatient
stay. Prompt, effective antimicrobial administration requires new tools to improve recognition, in addition to
continued etiological surveillance.
WHAT’S KNOWN ON THIS SUBJECT: Childhood
bacteremia caused by vaccine-preventable
organisms has substantially declined over the
last decade. Recognition of bacteremia in
children is difﬁcult, and delayed administration
of antibiotics is associated with poor outcomes.
Adults with health care–associated Gram-
negative bacteremia experience delays in
receiving appropriate antibiotics.
WHAT THIS STUDY ADDS: Bacteremia in children
presenting to the emergency department is
increasingly health care associated and resistant
to empirical antibiotics. These infections are
associated with increased length of stay. Rates of
Gram-negative bacteremia have increased, and
children with Gram-negative bacteremia
experience delayed antibiotic administration.
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Acute infections are a common reason
for presentation to the children’s
emergency department (ED).1 In
young children presenting with an
acute febrile illness, serious bacterial
infection occurs in ∼7%. Bacteremia
occurs in 1 in 250 febrile children
aged ,5 years and may be difﬁcult to
recognize.2
Bacteremia is associated with
signiﬁcant mortality and morbidity in
children. Immediately before the
introduction of the pneumococcal
vaccine in the United Kingdom, 20%
of childhood mortality was infection
related, with “septicemia” the most
commonly documented cause of
death.3 The etiology of pediatric
bacteremia in the United Kingdom
has evolved substantially as the
immunization schedule has expanded.
The incidence of vaccine-preventable
infections has declined,4 while that of
Gram-negative infections has
increased.5
Timely, effective antimicrobial
therapy is fundamental to the
management of serious infections in
children. Delayed recognition of
meningococcal disease,6 and
suboptimal resuscitation of septic
shock, contribute to mortality in
children.7,8 The Surviving Sepsis
Campaign recommends
administration of antibiotics within 1
hour of recognition of severe sepsis.9
Historically, serious infections have
been categorized according to the
timing of their identiﬁcation into
“community-acquired” and “hospital-
acquired” infection. These categories
were used to inform the likely
etiology and to guide empirical
treatment. There is an increasing
awareness of patients who, although
they acquire serious infections in the
community, share the characteristics
of patients with “hospital-acquired”
infections. Such occurrences have
been termed health care–associated
(HCA) infections.10 In adults, HCA
bacteremia is associated with delayed
administration of appropriate
antibiotics.11 To date, no validated
deﬁnition of HCA bacteremia is in use
in children.12
The objective of the present study
was to describe the etiology of
bacteremia by using data from
children presenting to the Alder Hey
Children’s Hospital ED between 2001
and 2011. Our goal was to explore the
impact of temporal changes on
outcomes, including the timeliness
and appropriateness of empirical
antibiotic therapy.
METHODS
A retrospective time series analysis
was conducted of all clinically
signiﬁcant episodes of bacteremia
presenting via the Alder Hey
Children’s Hospital ED. This children’s
ED is the busiest in the United
Kingdom, with ∼60 000 attendances
per year. All positive results of blood
culture isolates from 2001 to 2011
(inclusive) were identiﬁed. Positive
culture results isolated .48 hours
after presentation, or associated with
a hospital admission in the previous
month, were considered hospital-
acquired and excluded. Isolates
commonly considered commensals
were included if they were cultured
on .1 occasion within 48 hours.13
Clinical data relating to each episode
were extracted from clinical notes
and the hospital electronic database.
Recorded data included demographic
characteristics and signiﬁcant
comorbidities, including the presence
or absence of a central venous line
(CVL). Commonly used markers of
infection (white blood cell count,
neutrophil count, platelets, and
C-reactive protein) were extracted
electronically.
To examine trends and to compare
our data with published evidence, we
grouped episodes of Streptococcus
pneumoniae, Neisseria meningitidis,
and Haemophilus inﬂuenzae as
vaccine-preventable infections; Gram-
negative infections were similarly
grouped. For the remaining Gram-
positive infections, we differentiated
between typically pathogenic
organisms in healthy children such as
Staphylococcus aureus (typical Gram-
positive) and those considered to be
associated with the health care
setting, such as coagulase-negative
Staphylococcus (ie, other Gram-
positive).
Deﬁnitions
Community-acquired bacteremia was
deﬁned as the identiﬁcation of
a signiﬁcant pathogen in a blood
culture taken within 48 hours of
presentation to the ED (in the
absence of admission to the hospital
in the previous month).
HCA bacteremia was deﬁned as the
identiﬁcation of a signiﬁcant
pathogen in a blood culture taken
within 48 hours of presentation to the
ED in the following children: those
with an indwelling device (eg, CVL,
ventriculoperitoneal shunt, prosthetic
material); those with primary or
acquired immunodeﬁciency; those
requiring regular hospital-based
intervention (eg, hemodialysis,
intravenous therapies); and preterm
infants ,12 months from discharge
from the neonatal unit.
Empirical therapy was deﬁned as
therapy instituted before
microbiologic evidence of infection,
limited to 24 hours from presentation
to the ED. Therapy instituted beyond
this period, or where there was
documentation of microbiological
advice, was termed “directed.”
Susceptibility to empirical therapy
was deﬁned as susceptibility to the
empirical therapy initiated by the
clinical team. Susceptibility was
determined by breakpoints in use at
the time of isolation, according to
methods of the British Society for
Antimicrobial Chemotherapy.14
Statistical Methods
Statistical analysis was undertaken in
R version 3.0.1.15 A detailed
explanation of the statistical methods
is described in the Supplemental
Appendix.
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Continuous data were described
according to medians and
interquartile ranges, and comparison
between groups was performed by
using the Kruskal-Wallis test.
Categorical variables were expressed
as percentages with 95% conﬁdence
intervals (95% CIs). Groups were
compared by using the x2 test.
Time Series Analysis
Poisson regression was used to model
weekly counts of bacteremia with
weekly ED attendance as an offset.
Logistic regression was used to model
the likelihood over time (ie, the ﬁtted
likelihood) that each clinical episode
occurred in a child with an indwelling
CVL or that the isolate was
susceptible to empirical antibiotic
therapy.
Inspection of these models suggested
an initial increase in the likelihood of
a clinical episode occurring in a child
with an indwelling CVL, with
a subsequent reduction from 2008. In
parallel, there was an initial reduction
in the likelihood of an isolate being
susceptible to empirical antibiotics,
with an increase after 2008. Late in
2007, the hospital increased
investment in specialist intravenous
nurses, with responsibility for
training in the management of CVLs.
We considered this intervention to be
a plausible explanation for the
observed variation, and we
implemented a piecewise ﬁt of time
with the breakpoint speciﬁed
according to the time of the clinical
intervention. Inclusion of the
piecewise variable improved the ﬁt of
the model to the data.
Multivariable Analysis of Clinical
Outcomes
Length of stay (LOS) and time to
empirical antibiotic administration
were assessed by using multivariable
linear regression. Both factors were
log-transformed to meet the
assumption of linearity between
outcome and explanatory variables.
In the model assessing time to
antibiotic administration, a piecewise
ﬁt for platelets was undertaken and
found to improve the ﬁt of the model.
A maximal model of all variables with
a P value ,.1 was ﬁt before model
simpliﬁcation was undertaken in
a backward stepwise process.
The use of anonymized data was
approved by the research department
of the Alder Hey Children’s Hospital.
RESULTS
Between 2001 and 2011, a total of
692 clinically signiﬁcant blood
cultures were identiﬁed in children
sampled within 48 hours of
presentation to the ED. These
cultures represented 575 episodes of
bacteremia in 525 children.
Clinical Characteristics of Children
The characteristics of the 525
children presenting with bacteremia
are summarized in Table 1.
Signiﬁcant comorbidities were
present in 151 children (29%). The
most common comorbidities were
gastrointestinal (Supplemental
Table 5), and many of these children
(22 of 25) had indwelling CVLs for
the purpose of parenteral nutrition.
Children with Gram-negative isolates
were younger and more likely to have
signiﬁcant comorbidities or an
indwelling CVL than those with
vaccine-preventable or typical Gram-
positive isolates. Mortality in children
with other Gram-positive infections
was higher (6 of 37) than in other
groups (odds ratio: 5.15 [95% CI:
1.60–15.8] vs vaccine-preventable
isolates).
Children with HCA bacteremia were
older than those with community-
acquired bacteremia. LOS in children
with HCA bacteremia was prolonged
by 3.9 days versus community-
acquired bacteremia (95% CI:
2.3–5.8). Mortality and admission to
the PICU did not differ between these
groups (Table 2).
Etiology of Bacteremia in the
Children’s ED
Isolated organisms varied according
to age (Fig 1). In early infancy, the
most common organisms were
Escherichia coli and Group B
streptococcus. There were 47
presentations of neonatal sepsis,
including 1 of early-onset disease
(Group B streptococcus).
S pneumoniae was most common
overall. S pneumoniae and
N meningitidis occurred more
TABLE 1 Clinical Characteristics of 525 Children Presenting to the ED With Bacteremia According to Type of Organism
Variable Median IQR Vaccine-Preventable
(n = 221)
Typical Gram-Positive
(n = 149)
Gram-Negative
(n = 118)
Other Gram-Positive
(n = 37)
P
Age, y 1.52 0.42–4.27 1.80 (0.83–3.88) 1.58 (0.13–6.82) 0.82 (0.20–3.08) 1.64 (0.69–11.45) ,.001a
LOS, d 6 3–10 6 (4–9) 7 (3–13) 6 (4–10) 7 (2–11) .5a
% 95% CI n (%) n (%) n (%) n (%)
CM 28.8 25.1–32.8 36 (16.3) 42 (28.2) 51 (43.2) 22 (59.5) ,.001b
CVL 9.0 6.80–11.7 3 (1.40) 6 (4.02) 26 (22.0) 12 (32.4) .001c
PICU 18.9 15.8–22.5 56 (25.3) 23 (15.4) 13 (11.0) 7 (18.9) .007b
Mortality 4.57 3.09–6.71 8 (3.62) 6 (4.02) 4 (3.39) 6 (16.2) .005c
CM, signiﬁcant comorbidity; IQR, interquartile range.
a Kruskal-Wallis test.
b x2 test.
c Monte Carlo simulation.
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commonly between the ages of 1 and
5 years, whereas S aureus was the
most common organism in children
aged .5 years. Most meningococcal
isolates (87 of 96) were Group B; the
remainder were Groups C (n = 5),
W135 (n = 3), and Y (n = 1). Two
episodes of methicillin-resistant
S aureus bacteremia occurred over
the 11-year period; 1 episode was
associated with ventriculitis in a child
with a ventriculoperitoneal shunt,
and 1 episode was in a previously
well child. There were 17
polymicrobial infections in 13
children; 12 had signiﬁcant
comorbidities, and 8 had CVLs in situ.
Isolated organisms are summarized
in Table 3.
Time Series Analysis
The rate of clinically signiﬁcant
bacteremia in children presenting to
the ED was 1.42 per 1000
attendances (95% CI: 1.31–1.53).
The cumulative frequency plot
reveals a declining rate of vaccine-
preventable isolates, including
S pneumoniae, and an increasing rate
of Gram-negative isolates
(Supplemental Fig 4).
Poisson regression was used to model
the observed rate of bacteremia
(Fig 2). For the overall rate of
bacteremia, neither the trend over
time (P = .18) nor the seasonal effect
(P = .17) was statistically signiﬁcant.
Bacteremia caused by vaccine-
preventable isolates including
S pneumoniae was highly seasonal
(P , .001). From 2001 to 2011, its
rate declined from 1.32 to 0.37 per
1000 ED attendances at an annual
rate of reduction of 10.6% (95% CI:
6.6–14.5). The pneumococcal
conjugate vaccine (PCV) was
introduced into the UK immunization
schedule in September 2006. When
incorporated into the regression
model, PCV was associated with
a 49% reduction in pneumococcal
bacteremia (95% CI: 32–74) from
0.50 to 0.25 per 1000 attendances. By
contrast, the rate of Gram-negative
bacteremia increased from 0.24 to
0.53 per 1000 ED attendances (P =
.007). The ﬁtted seasonal effect in the
Gram-negative model, although not
statistically signiﬁcant (P = .07),
exhibited a peak in summer, in
contrast to that of the vaccine-
preventable model, which peaked in
winter.
The rate of community-acquired
bacteremia was reduced from 0.93 to
0.57 per 1000 ED attendances (P =
.005) between 2001 and 2011, while
the rate of HCA bacteremia increased
from 0.17 to 0.43 per 1000 (P = .002).
The proportion of clinical episodes
occurring in children with an
indwelling CVL increased from 3.2%
in 2001 (95% CI: 1.47–6.84) to
a peak of 26.5%, before declining to
21.8% in 2011 (95% CI: 12.9–34.3).
In parallel, the likelihood that an
isolate was susceptible to empirical
therapy was reduced from 96.3%
(95% CI: 92.1–98.2) to 82.6% (95%
CI: 69.8–90.7) between 2001 and
2011; it reached a nadir of 74.4% in
2008. These trends are illustrated in
Fig 3. LOS, likelihood of PICU
admission, and mortality did not
change over time.
Timeliness and Appropriateness of
Empirical Antibiotics
The empirical antibiotic protocol was
documented in 563 of 575 clinical
TABLE 2 Clinical Characteristics of Community-Acquired Bacteremia and HCA Bacteremia
Characteristic Community-Acquired (n = 444) HCA (n = 81) P
Median age, y (IQR) 1.43 (0.35–3.88) 2.32 (0.96–6.48) .001a
Median LOS, d (IQR) 6 (3–9) 9 (4–18) ,.001a
PICU, % (95% CI) 19.0 (15.6–22.9) 18.5 (11.6–28.3) .15b
Mortality, % (95% CI) 4.1 (2.6–6.3) 7.4 (3.4–15.2) .25c
Group ,.001b
Vaccine-preventable 207 14
Typical Gram-positive 133 16
Gram-negative 82 36
Other Gram-positive 22 15
Median time to antibiotics, min (IQR) 181 (59–321) 218 (91–353) .15a
IQR, interquartile range.
a Kruskal-Wallis test.
b x2 test.
c Monte Carlo simulation.
FIGURE 1
Proportion of bacteremia episodes of each isolate according to age group.
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episodes (Supplemental Table 6). For
children with no indwelling CVL, 375
of 480 received monotherapy (most
commonly, cefotaxime [289 of 393]).
In combination treatments,
cefotaxime was also invariably used,
along with gentamicin,
benzylpenicillin, or amoxicillin. In
children with an indwelling CVL,
combination therapy was commonly
used (46 of 83), particularly with
teicoplanin and gentamicin.
We were able to deﬁne empirical
susceptibility in 527 of 575 cases.
Vaccine-preventable isolates were
almost universally susceptible to
empirical therapy (217 of 219),
whereas 22% (29 of 131) of Gram-
negative isolates were resistant (P ,
.001). Data on time to antibiotic
administration were available for
78% (444 of 575) of all episodes.
Median time to antibiotic
administration was ∼3 hours and
varied according to the type of
organism (Table 4). Children with
vaccine-preventable infections
received empirical antibiotics more
quickly than children with other
types of infection.
To explore this relationship,
a multivariable model of time to
antibiotics was developed
(Supplemental Table 7). After
adjustment for other explanatory
variables, time to antibiotics was
increased by 57 minutes for Gram-
negative infections compared with
vaccine-preventable infections. Older
children received antibiotics later
than younger children. Overall, time
to antibiotics increased by ∼3
minutes per year of the study (P =
.006 for linear trend).
DISCUSSION
In describing the changing etiology of
bacteremia in the busiest children’s
ED in the United Kingdom, we have
shown a reduction in vaccine-
preventable bacteremia, coincident
with an increase in Gram-negative
bacteremia. The rate of pneumococcal
bacteremia has been halved since the
introduction of the PCV. These trends
afﬁrm data from surveillance studies
of invasive bacterial infections
internationally.4,5,16–18 We identiﬁed
a seasonality to Gram-negative
bacteremia with a summer peak;
although not statistically signiﬁcant,
this ﬁnding is consistent with other
published data.19,20
Our analysis illustrates the changing
characteristics of children presenting
to the ED with bacteremia.
Increasingly, these are children with
underlying comorbidities and
indwelling CVLs. The rate of HCA
bacteremia is increasing. The
proportion of episodes involving
children with CVLs increased to
a peak in 2008 before declining
toward the end of the study. This
ﬁnding occurred in parallel with an
initial reduction in antibiotic
susceptibility, which also improved
after 2008. This outcome likely
reﬂects more children with CVLs
receiving total parenteral nutrition in
the community. Unpublished data
from Alder Hey Children’s Hospital
(S. Melville, personal communication,
2013) reveals a threefold increase in
CVL-associated infection rates with
the use of total parenteral nutrition
(from 3.3 to 10.4 per 1000 line-days).
At the end of 2007, the hospital
increased investment in specialist
intravenous nurses, with
responsibility for training in the
management of CVLs. This
intervention may explain the later
reduction in children with CVL-
associated infections presenting to
the ED.
The changing etiology of childhood
bacteremia in the ED was not
associated with temporal changes in
mortality or PICU admission. HCA
bacteremia was associated with an
increased LOS, irrespective of the
responsible organism. Other
investigators have related increased
TABLE 3 Predominant Organisms According
to Group
Organism N %
Vaccine preventable, n = 223
S pneumoniae 109 19.0
N meningitidis 96 16.7
H inﬂuenzae (type B) 18 3.1
Typical Gram-positive, n = 149
S aureus 89 15.4
Group B streptococcus 32 5.6
Group A streptococcus 28 5.9
Gram-negative, n = 152
E coli 59 10.3
Klebsiella sp 26 4.5
Acinetobacter sp 11 1.9
Enterobacter sp 10 1.7
Pseudomonas sp 10 1.7
Salmonella sp 9 1.6
Moraxella catarrhalis 9 1.6
Other 18 3.2
Other Gram-positive, n = 51
Coagulase-negative staphylococcus 21 3.5
Enterococcus sp 19 3.3
Nonpyogenic streptococcus 6 1.0
Other 5 0.9
FIGURE 2
Fitted rate of pediatric bacteremia per 1000 attendances to the Alder Hey Children’s Hospital ED
between 2001 and 2011. The discontinuity in the ﬁt for S pneumoniae is due to the introduction of
the PCV in September 2006.
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LOS in adults to HCA bacteremia,21
but we are unaware of pediatric data
detailing the same. To date, this
category of infection remains poorly
deﬁned in children.
Despite acceptance that time to
antibiotic administration inﬂuences
outcome in sepsis,22 few studies have
reported time to antibiotic
administration in the pediatric
ED.23,24 We found that the changing
nature of bacteremia in the pediatric
ED has implications for both
recognition and management.
A median time to antibiotic
administration of 3 hours is
comparable with other data.25
Empirical therapy took longer to
initiate in children with Gram-
negative infections than in children
with vaccine-preventable infections,
even with adjustment for other
explanatory variables. Furthermore,
multivariable modeling allowed us to
estimate an increase in time to
antibiotics of 38 minutes over the
11 years of the study, regardless of
changes in etiology. These changes are
likely multifactorial, but the implication
is that additional resources in
diagnostics and training will be required
to minimize delays in the treatment of
these most invasive infections.
Over 11 years, susceptibility to
empirical antibiotic protocols
declined. Adults with Gram-negative
HCA bacteremia experience delays in
appropriate antibiotic therapy,11 and
mortality is increased when initial
empirical therapy is inadequate.26
Death in children is uncommon even
in serious infection, and we failed to
draw an association between death or
likelihood of PICU admission and
inappropriate empirical antibiotics.
The present study had several
limitations. It was a retrospective,
single-center study of culture-positive
bacteremia conducted in the pediatric
ED. Blood culture yield is affected by
the use of previous antibiotics (more
so than polymerase chain reaction
assays).27 Collecting data on previous
antibiotics was impractical in this
retrospective analysis. Community
antibiotic prescribing for children in
the United Kingdom decreased
substantially in the 1990s,28,29
although some data suggest an
increase through the course of the
present study.30 This ﬁnding would
not account for the reduction in
pneumococcal bacteremia, for which
there was no temporal trend before
the introduction of the PCV. An
increase in prehospital antibiotic use
may have affected blood culture yield
over time, however, particularly if this
use was well targeted toward
children with bacteremia.
We have not accounted for changes to
the population of the hospital
catchment area but have instead
incorporated ED attendance. Over
time, there was no change in medical
attendances to the ED.
Based on the published literature, we
developed a pragmatic deﬁnition of
HCA bacteremia.12 To date, no such
deﬁnition has been established in
pediatric medicine. We identiﬁed
a number of surrogate markers of
frequent exposure to health care
environments but were unable to
collect robust data to quantify this
occurrence in terms of how
frequently or how recently exposure
occurred in individual clinical
episodes. Understanding this
exposure better, thereby establishing
a valid deﬁnition of HCA bacteremia,
would help to guide empirical
treatment in the ED. Because our
deﬁnition was applied consistently
across the 11 years of the data set, we
believe our description of temporal
trends is robust.
Data regarding time to antibiotics
were missing in ∼20% of clinical
cases. We restricted our analysis to
time to empirical therapy, although
others have reported time to
“appropriate” therapy.11 We explored
explanatory variables that may
inﬂuence time to antibiotics and
which were available in the clinical
FIGURE 3
Fitted likelihood over time that an isolate was susceptible to empirical therapy (top) and that an
episode occurred in a child with an indwelling CVL (bottom). Time was ﬁt as a piecewise term to
incorporate a clinical intervention. Inclusion of the piecewise term improved the model ﬁt. Dotted
red lines are 95% CIs.
TABLE 4 Time to Antibiotics According to Type of Organism
Organism Median, min IQR P
All 184 62.5–330.5
Vaccine-preventable 130 34.5–297 ,.001
Typical Gram-positive 256 118–376
Gram-negative 184 95.5–356
Other Gram-positive 253.5 147–401
IQR, interquartile range.
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notes. Other studies have used
validated measures of disease
severity (eg, the Glasgow
Meningococcal Septicaemia
Prognostic Score) and demonstrated
an association with time to antibiotic
administration.23 A comparable
measure of illness severity may help to
explain the variation reported, although
no such tool is currently in use in all
acutely unwell children in the ED.
We assumed that variation in time to
antibiotics was related to clinical
recognition. Time to antibiotics is also
used as a measure of crowding in
EDs. Some investigators have
identiﬁed an association between
markers of ED crowding and time to
antibiotic administration in young
infants,31 although not consistently.32
We did not collect data on ED
crowding. There was no overall
increase in numbers presenting to the
Alder Hey Children’s Hospital ED over
the course of the study, nor was there
an association between time of day,
day of the week, or time of year (all
factors that are associated with the
volume of ED activity) and time to
antibiotic administration.
CONCLUSIONS
We describe the evolving etiology of
children with bacteremia presenting
to the UK’s busiest children’s ED.
Increasingly, these infections are
considered HCA. They are more likely
to be resistant to empirical therapy,
more difﬁcult to recognize, and are
associated with a prolonged LOS.
Prompt and effective antimicrobial
treatment of bacteremia requires
improved diagnostic tools in addition
to continued etiological surveillance.
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